Literature DB >> 9710130

The dural tail sign in the diagnosis of meningiomas.

J P Graham1, S M Newell, A K Voges, G D Roberts, J M Harrison.   

Abstract

In humans the dural tail is a sign seen on contrast enhanced T1 weighted magnetic resonance images. This finding is considered specific for meningioma. The purpose of this study was to determine how often the dural tail occurs in cats and dogs and whether it is a specific sign for meningiomas in these species. MR examinations for eighteen dogs and four cats with proven diagnoses were reviewed. Diagnoses included ten meningiomas (seven dogs and three cats), three gliomas, two pituitary tumors, single examples of two other tumor types and five patients with mass lesions due to inflammatory disease. Contrast enhanced T1 weighted images were evaluated independently by three of the authors for the presence of a dural tail, without knowledge of the diagnoses. The results were compared to the diagnosis for each patient and the performance of individual reviewers compared. When their results were averaged, the reviewers reported the presence of a dural tail in 6 of 10 (60%) meningiomas, although detection varied between observers from 40% to 80%. Each reviewer had one false positive result, two reported a dural tail with a chromophobe adenocarcinoma and one with a toxoplasma meningoencephalitis. When a dural tail is seen an associated mass is most likely a meningioma. It is uncertain whether the dural tail represents neoplastic infiltration beyond the margins of the meningioma. This should be considered when planning treatment.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9710130     DOI: 10.1111/j.1740-8261.1998.tb01609.x

Source DB:  PubMed          Journal:  Vet Radiol Ultrasound        ISSN: 1058-8183            Impact factor:   1.363


  9 in total

1.  Diagnostic ophthalmology.

Authors:  Cheryl L Cullen; Patricia L Rose; Bruce H Grahn
Journal:  Can Vet J       Date:  2002-04       Impact factor: 1.008

2.  Secondary extracranial paranasal sinus meningioma in a dog.

Authors:  Eunbee Kim; Vincent W Carroll; Nahvid Etedali; Alexandre B Le Roux
Journal:  Can Vet J       Date:  2022-09       Impact factor: 1.075

3.  Feline meningioma with extensive nasal involvement.

Authors:  Jorge Pérez-Accino; Anna Suñol; Elizabeth Munro; Adrian W Philbey; Katia Marioni-Henry
Journal:  JFMS Open Rep       Date:  2019-02-26

Review 4.  Companion animal models of neurological disease.

Authors:  Brittanie Partridge; John H Rossmeisl
Journal:  J Neurosci Methods       Date:  2019-11-13       Impact factor: 2.390

5.  Comparison of Canine and Feline Meningiomas Using the Apparent Diffusion Coefficient and Fractional Anisotropy.

Authors:  Masae Wada; Daisuke Hasegawa; Yuji Hamamoto; Yoshihiko Yu; Rikako Asada; Aki Fujiwara-Igarashi; Michio Fujita
Journal:  Front Vet Sci       Date:  2021-01-11

6.  Agreement and differentiation of intradural spinal cord lesions in dogs using magnetic resonance imaging.

Authors:  Maya S Krasnow; John F Griffin; Jonathan M Levine; Wilfried Mai; Theresa E Pancotto; Marc Kent; Thomas R Harcourt-Brown; Sheila C Carrera-Justiz; Lindsey J Gilmour; Amanda E Masciarelli; Nicholas D Jeffery
Journal:  J Vet Intern Med       Date:  2021-12-03       Impact factor: 3.333

Review 7.  Advances in diagnostic and treatment modalities for intracranial tumors.

Authors:  P J Dickinson
Journal:  J Vet Intern Med       Date:  2014-05-09       Impact factor: 3.333

Review 8.  Canine Primary Intracranial Cancer: A Clinicopathologic and Comparative Review of Glioma, Meningioma, and Choroid Plexus Tumors.

Authors:  Andrew D Miller; C Ryan Miller; John H Rossmeisl
Journal:  Front Oncol       Date:  2019-11-08       Impact factor: 6.244

9.  Clinical and magnetic resonance imaging features of lymphoma involving the nervous system in cats.

Authors:  Alexane Durand; Erin Keenihan; Daniela Schweizer; Arianna Maiolini; Julien Guevar; Anna Oevermann; Rodrigo Gutierrez-Quintana
Journal:  J Vet Intern Med       Date:  2022-01-20       Impact factor: 3.333

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.